Regeneron Pharmaceuticals (REGN) is one of those high-flying biotech names that is slowly maturing into a big pharma companyHowever, the stock of Regeneron tells quite a more volatile storyJust witness the severe moves up/down just since last summerFrom a high around $450 to a low near $320, that is a huge range -- and it occurred on the span of e...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.